Details for Patent: 5,412,095
✉ Email this page to a colleague
Summary for Patent: 5,412,095
Title: | Terazosin monohydrochloride and processes and intermediate for its production |
Abstract: | The present invention provides a non-solvated crystalline polymorph of terazosin monohydrochloride designated Form III and methods for its preparation. Also disclosed is terazosin monohydrochloride methanolate and processes for its production as well as processes for its conversion to other crystalline forms of terazosin monohydrochloride. |
Inventor(s): | Morley; James A. (Gurnee, IL), Bauer; John F. (Lake Bluff, IL), Patel; Ramesh F. (Chicago, IL), Henry; Rodger E. (Waukegan, IL), Spanton; Stephen G. (Grayslake, IL) |
Assignee: | Abbott Laboratories (Abbott Park, IL) |
Application Number: | 08/246,526 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 5,412,095
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,412,095
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 130853 | ⤷ Sign Up | |||
Austria | 182592 | ⤷ Sign Up | |||
Canada | 2107382 | ⤷ Sign Up | |||
Canada | 2143974 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |